相关实验视频

Updated: Jun 23, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

在免疫疗法时代的空间分离放射治疗

Matthew T McMillan¹, Atif J Khan¹, Simon N Powell¹

¹Department of Radiation Oncology.

Seminars in radiation oncology

|June 16, 2024

概括

空间分离放射疗法 (SFRT) 使用独特的剂量分布来潜在地提高对瘤的免疫反应. 这种方法可以增强瘤回归和全身免疫力,即使在具有挑战性的情况下.

科学领域:

辐射瘤学辐射瘤学
免疫学免疫学免疫学
医学物理医学物理

背景情况:

空间分离放射疗法 (SFRT) 建立在历史的网格疗法之上.
现代SFRT使用强度调制来创建受控制的冷剂量区域.
核心假设是SFRT可以克服辐射诱导的免疫抑制.

研究的目的:

探索SFRT在增强抗瘤免疫反应方面的潜力.
研究SFRT的临床和临床前疗效,特别是在缺氧瘤中.
评估在SFRT中低剂量和高剂量放射治疗的整合,以获得协同效应.

主要方法:

实施二维和三维SFRT,剂量分布具有冷点.
使用极端剂量分布的临床前模型 (例如,减半).
使用三维SFRT (格子状剂量分布) 进行临床试验.

主要成果:

临床经验表明,SFRT可以诱导显著的瘤回归,即使是在大型的缺氧瘤中.
临床前模型表明,通过极端剂量分布,完全消除瘤,增强全身抗瘤免疫力.
三维SFRT试验报告了有希望的瘤控制和毒性概况.

结论:

SFRT利用不同辐射剂量的补充性免疫调节效应.
SFRT显示出诱导强大的免疫反应和全身抗瘤免疫的潜力.
目前正在进行的试验正在探索SFRT与免疫疗法的协同作用.

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.